SLC2A3 and glioma: The correlation of miR-106a-5p and SLC2A3 has been demonstrated in human glioma, and inhibition of SLC2A3 by miR-106a attenuated cell proliferation, inhibited glucose uptake, and conferred a favorable survival for patients with glomerular basement membrane disease (Dai et al., 2013).